Reuters logo
BRIEF-Ra Pharmaceuticals reports Q2 loss per share $0.56
2017年8月9日 / 晚上8点28分 / 2 个月前

BRIEF-Ra Pharmaceuticals reports Q2 loss per share $0.56

Aug 10 (Reuters) - Ra Pharmaceuticals Inc

* Ra Pharmaceuticals reports second quarter 2017 financial results and provides corporate update

* Q2 loss per share $0.56

* Q2 earnings per share view $-0.52 -- Thomson Reuters I/B/E/S

* Ra Pharmaceuticals Inc - ‍expects that its cash and cash equivalents will be sufficient to fund operations through end of 2018​

* Says no revenue recorded in three months ended June 30, 2017, compared to $3.0 million for same period in 2016

* Q2 earnings per share view $-0.52, revenue view $833330.00 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below